Literature DB >> 14732693

The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function.

Dawn Mattoon1, Peter Klein, Mark A Lemmon, Irit Lax, Joseph Schlessinger.   

Abstract

Quantitative epidermal growth factor (EGF)-binding experiments have shown that the EGF-receptor (EGFR) is displayed on the surface of intact cells in two forms, a minority of high-affinity and a majority of low-affinity EGFRs. On the basis of the three-dimensional structure of the extracellular ligand binding domain of the EGFR, it was proposed that the intramolecularly tethered and autoinhibited configuration corresponds to the low-affinity receptor, whereas the extended configuration accounts for the high-affinity EGFRs on intact cells. Here we test this model by analyzing the properties of EGFRs mutated in the specific regions responsible for receptor autoinhibition and dimerization, respectively. Our results show that mutagenic disruption of the autoinhibitory tether in EGFR results in a decrease in the dissociation rate of EGF without a detectable change in EGFR activation and signaling through EGFR even in response to stimulation with low concentrations of EGF. Mutagenic disruption of the dimerization arm, on the other hand, increased the rate of EGF dissociation and impaired EGFR activation and signaling via the EGFR. This study demonstrates that the extended configuration of EGFR does not account for the apparent high-affinity EGF-binding to EGFR on intact cells. Furthermore, the autoinhibition conferred by the tethered configuration of the extracellular ligand-binding domain provides only a limited control of EGFR function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732693      PMCID: PMC327118          DOI: 10.1073/pnas.0307286101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  A putative molecular-activation switch in the transmembrane domain of erbB2.

Authors:  Sarel J Fleishman; Joseph Schlessinger; Nir Ben-Tal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

2.  Signal transduction. Autoinhibition control.

Authors:  Joseph Schlessinger
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

3.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

Authors:  Kathryn M Ferguson; Mitchell B Berger; Jeannine M Mendrola; Hyun Soo Cho; Daniel J Leahy; Mark A Lemmon
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

4.  A mutant epidermal growth factor receptor with defective protein tyrosine kinase is unable to stimulate proto-oncogene expression and DNA synthesis.

Authors:  A M Honegger; D Szapary; A Schmidt; R Lyall; E Van Obberghen; T J Dull; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

5.  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Authors:  Hideo Ogiso; Ryuichiro Ishitani; Osamu Nureki; Shuya Fukai; Mari Yamanaka; Jae-Hoon Kim; Kazuki Saito; Ayako Sakamoto; Mio Inoue; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

Review 6.  Epidermal growth factor receptor: mechanisms of activation and signalling.

Authors:  Robert N Jorissen; Francesca Walker; Normand Pouliot; Thomas P J Garrett; Colin W Ward; Antony W Burgess
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

7.  A structure-based model for ligand binding and dimerization of EGF receptors.

Authors:  Peter Klein; Dawn Mattoon; Mark A Lemmon; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

Review 8.  An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.

Authors:  Antony W Burgess; Hyun-Soo Cho; Charles Eigenbrot; Kathryn M Ferguson; Thomas P J Garrett; Daniel J Leahy; Mark A Lemmon; Mark X Sliwkowski; Colin W Ward; Shigeyuki Yokoyama
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

9.  Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; D Szapary; A Komoriya; R Kris; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

10.  Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; F Bellot; E Van Obberghen; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  45 in total

1.  Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.

Authors:  Zhiyong Zhang; Willy Wriggers
Journal:  Biochemistry       Date:  2011-02-18       Impact factor: 3.162

2.  GxxxG motifs, phenylalanine, and cholesterol guide the self-association of transmembrane domains of ErbB2 receptors.

Authors:  Anupam Prakash; Lorant Janosi; Manolis Doxastakis
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

3.  The tethering arm of the EGF receptor is required for negative cooperativity and signal transduction.

Authors:  Sangeeta Adak; Diana DeAndrade; Linda J Pike
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

Review 4.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

5.  Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions.

Authors:  Christian Jost; Jakob C Stüber; Annemarie Honegger; Yufan Wu; Alexander Batyuk; Andreas Plückthun
Journal:  Protein Sci       Date:  2017-07-05       Impact factor: 6.725

6.  On the nature of low- and high-affinity EGF receptors on living cells.

Authors:  Ferruh Ozcan; Peter Klein; Mark A Lemmon; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-29       Impact factor: 11.205

7.  Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.

Authors:  Jennifer L Macdonald; Linda J Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

Review 8.  Epidermal growth factor receptor inhibitors in colorectal cancer treatment: what's new?

Authors:  M Ponz-Sarvisé; J Rodríguez; A Viudez; A Chopitea; A Calvo; J García-Foncillas; I Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Authors:  Jessica P Dawson; Mitchell B Berger; Chun-Chi Lin; Joseph Schlessinger; Mark A Lemmon; Kathryn M Ferguson
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 10.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.